Skip to content
naulon
Get started

No retraction, correction or concern found when last checked on Oct 21, 2026.

RND multidrug efflux pumps: what are they good for?

Carolina Alvarez-Ortega, Jorge Olivares, José L. Martínez

Frontiers in Microbiology · 2013

doi:10.3389/fmicb.2013.00007

Abstract

Multidrug efflux pumps are chromosomally encoded genetic elements capable of mediating resistance to toxic compounds in several life forms. In bacteria, these elements are involved in intrinsic and acquired resistance to antibiotics. Unlike other well-known horizontally acquired antibiotic resistance determinants, genes encoding for multidrug efflux pumps belong to the core of bacterial genomes and thus have evolved over millions of years. The selective pressure stemming from the use of antibiotics to treat bacterial infections is relatively recent in evolutionary terms. Therefore, it is unlikely that these elements have evolved in response to antibiotics. In the last years, several studies have identified numerous functions for efflux pumps that go beyond antibiotic extrusion. In this review we present some examples of these functions that range from bacterial interactions with plant or animal hosts, to the detoxification of metabolic intermediates or the maintenance of cellular homeostasis.

Full text

From PubMed Central, U.S. National Library of Medicine, as current on Oct 21, 2026. Paragraph numbers are ours, so an answer can point at one.

INTRODUCTION

Multidrug resistance (MDR) efflux pumps are relevant elements that contribute to both intrinsic and acquired resistance to toxic compounds in diverse life forms, including humans where they have a role in resistance to anti-cancer drugs, to bacteria, where they are involved in resistance to antibiotics. Unlike well-known horizontally acquired antibiotic resistance determinants, MDR efflux pumps are usually chromosomally encoded and the structural components of different systems are highly conserved in all members of a given bacterial species. MDR systems are ancient elements, present in bacterial genomes long before the use of antibiotics for the treatment of human infections. This, along with their ubiquity in different organisms, suggests that the main function of these elements goes beyond providing resistance to antibiotics. The fact that quinolones, a family of synthetic antibiotics, constitute a common substrate of MDR efflux pumps supports this notion. These observations also suggest that the recent selective pressure imposed by the use of antibiotics is not the main evolutionary driver for MDR efflux pumps.

Bacterial MDR efflux pumps can be grouped into five different structural families: the adenosine triphosphate (ATP)-binding cassette (ABC) superfamily, the multidrug and toxic compound extrusion (MATE) family, the major facilitator superfamily (MFS), the small multidrug resistance (SMR) family, and the resistance/nodulation/division (RND) superfamily. The activity of an efflux pump depends on the different types of energy source each system uses: ABC transporters are fueled by ATP hydrolysis; MFS, RND, and SMR use the proton-motive force and MATE transporters consist of Na+/H+ drug antiport systems.

The RND family includes several members that are relevant to antibiotic resistance in Gram-negative bacteria, whereas the MATE family has been mainly associated to resistance in Gram-positive microorganisms. This review will focus exclusively on RND efflux systems.

The crystallographic analysis of AcrB, a model member of the RND family, revealed that this protein forms a homotrimer, that associates into a tripartite complex along with an outer membrane protein (OMP, TolC) and a periplasmic membrane-fusion protein (MFP, AcrA; Figure 1). Usually the genes encoding for these proteins are found in a single operon, however, the gene encoding for the OMP can also be found elsewhere in the chromosome, as it happens with TolC in Escherichia coli; or is part of an operon encoding for a different efflux pump (Figure 2). The Pseudomonas aeruginosa RND efflux pump MexXY is an example of the latter, where the system uses the OprM porin encoded in the mexAB-OprM operon (Figure 2; ).

In this review we will address the different functional roles that RND efflux pumps may have in addition to mediating antibiotic resistance. Exhaustive information on structure, regulatory aspects, and antibiotic resistance can be found elsewhere.

Some of the most relevant roles so far identified include involvement in bacterial virulence, plant–bacteria interactions, trafficking of quorum sensing molecules, and detoxification processes from metabolic intermediates, and toxic compounds such as heavy metals, solvents, or antimicrobials produced by other microorganisms. A comprehensive review of all potential functions identified to date for all RND efflux pumps is beyond the scope of this review. Instead, we would like to discuss some selected examples of the ecological role that these systems may have in the absence of antibiotics. As stated above, we believe that the evolution of bacterial RND efflux pumps has been primarily driven by their physiological functions and not by the selective pressure imposed by the relatively recent human use of antibiotics. We consider the important role RND efflux pumps currently play in antibiotic resistance to be an evolutionary novelty stemming from the aforementioned use of antibiotics by humankind.

REGULATION OF RND EFFLUX SYSTEMS BY NATURAL EFFECTORS

The regulation of bacterial RND efflux systems is often mediated by global and local regulators, resulting in a multilayered control to optimize gene expression in response to specific cues. A number of positive and negative regulators along with their known mechanism of action have been reviewed elsewhere.

In most cases a transcriptional regulator (typically a repressor) is encoded upstream the operon coding for the efflux pump (Figure 2). This local regulator usually keeps expression of the efflux pump at a very low-level. High-level expression can be achieved either through an effector-mediated release of the repressed state or through mutations in one or more regulators. Activation may occur at different levels: (1) By inactivation of the local repressor that blocks the expression of the pump’s structural genes such as AcrR in E. coli, MexR in P. aeruginosa, or SmeT in Stenotrophomonas maltophilia; (2) By activation of a global transcriptional regulator like SoxS, RobA, or RamA in E. coli; (3) By switching on–off one or more steps that interlink regulatory cascades such as MtrR of Neisseria gonorrhoeae; and (4) Through the emergence and selection of mutations in key genes like mexT in P. aeruginosa.

Multidrug efflux pumps extrude a wide range of substrates. However, the number of effectors regulating them is lower in comparison. Understanding the mechanisms of regulation may help in deciphering the function of RND efflux pumps, since it is expected that different effectors trigger expression only when a given pump is required. RND efflux systems whose expression is controlled by natural inducers normally encountered during the course of infective processes have been studied in detail. Induction of expression by bile salts and fatty acids in enteric bacteria are perhaps the best studied examples of substances capable of modulating expression of these systems.

Expression of the acrAB system in E. coli is induced by decanoate and unconjugated bile salts usually encountered by the organism in the intestinal tract. The mechanism involves binding of these effectors to the Rob transcriptional regulator. Bile salts also induce expression of acrAB in Salmonella, however, in this case the effector binds the RamA transcriptional regulator. Interestingly, in both cases the inductor is also a substrate for the efflux system, thus allowing the cell to respond quickly to deleterious environmental substances. Additional examples of bile salts-mediated induction include the cmeABC system in Campylobacter jejuni, the vexD gene in Vibrio cholerae and various RND-type efflux system genes in Bacteroides fragilis. These examples strongly suggest that these systems are relevant to bacterial adaptation for surviving in the gut and that this may be their original function.

In this regard, it has been suggested that some efflux pumps from human commensals and pathogens have evolved to overcome the innate immunity of the host. For instance, the susceptibility to vertebrate antibacterial peptides in N. gonorrhoeae depends on the activity of the MtrCDE RND efflux pump. Notably, this efflux pump is required to achieve mutation-driven resistance to penicillin in N. gonorrhoeae and overexpression mutants present reduced susceptibility to several antibiotics and show an increase in in vivo fitness. MtrCDE, enhances experimental gonococcal genital tract infections in female mice, whereas the FarAB-MtrE efflux pump is not needed to colonize this environment. It has been suggested that FarAB-MtrE is important for the resistance of N. gonorrhoeae to certain long-chained fatty acids that are present in the rectum. Altogether these studies indicate that N. gonorrhoeae harbors efflux pumps each one responding to different environmental cues that enable adaptation for survival in different ecosystems.

Metal cations are another example of natural compounds capable of inducing expression of RND efflux pumps. Metals are required as cofactors in several bacterial processes. However, they are toxic at high concentrations. Consequently, bacteria harbor systems to maintain the cellular metal homeostasis. In some cases, this regulation implies that the efflux pump is involved in the extrusion of these toxic effectors. However, in other cases the situation is more complex and the effector is simply an environmental cue that indicates the type of ecosystem surrounding the organism. The cusCBA system in E. coli and mtrCDE system in N. gonorrhoeae constitute two of the most studied examples of metal-induced regulation among pathogenic bacteria. The CusCBA system confers tolerance to copper and silver ions. Both substrates serve as natural inducers for cusCBA expression, suggesting that this RND efflux pump may have been first selected to overcome the toxicity of these metals. As stated above, the MtrCDE system is involved in resistance to host-derived antibacterial peptides. It was recently reported that mtrCDE expression is indirectly regulated by free levels of iron through the regulation of its major transcriptional repressor, MtrR, by the MpeR transcriptional regulator. Under the proposed model, expression of the efflux system would increase under iron-limited conditions, a situation that bacteria can encounter over the course of the infection process. The P. aeruginosa CzcABC efflux system confers tolerance to zinc, cadmium, and cobalt and constitutes another example of metal-induced expression. The regulation occurs through the metal-inducible CzcRS two-component system that is activated in the presence of the system’s substrates or indirectly in the presence of copper.

THE ROLE OF EFFLUX PUMPS IN PLANT–BACTERIA INTERACTIONS

The rhizosphere is a complex ecosystem characterized by a high microbial activity that results in a bacterial population density that can be two orders of magnitude higher than in bulk soil. The structure of the rhizosphere’s microbiota is governed by the release of nutrients through plant root exudates and by the ecological relationships of the microorganisms present in this ecosystem. A transcriptomic analysis of Pseudomonas putida grown in the rhizosphere of maize revealed that the expression of different efflux pumps is induced in this ecosystem, thus suggesting a relevant function for the colonization of this environment. Plant exudates have been identified as good effectors of RND efflux pumps, and it has been shown that these secondary metabolites bind regulators of RND efflux pumps such as TtgR, the local repressor of the TtgABC system in P. putida. Some compounds produced by plants have antibacterial effects and it has been described the RND efflux pumps are required from the first steps of bacterial plant colonization to survival in plant tissues, possibly due to their involvement in protection against these compounds. This is the case of Erwinia amylovora, the cause of fire blight disease in rosaceous plants. The plantlet toxic metabolites naringenin and phloretin are good inducers of the efflux pump acrAB in this bacterial species, and E. amylovora acrAB mutants are much less virulent that their wild-type counterpart. A similar situation occurs in Agrobacterium tumefaciens. Coumestrol, an antimicrobial root-exudated flavonoid, is both a substrate and an inducer of expression of the ifeABR efflux system. The fact that this system is needed for effective root colonization indicates that it plays an important role in A. tumefaciens resistance to plant-produced antimicrobials.

Comprehensive analyses on Erwinia chrysanthemi RND efflux pumps revealed that each system may differentially contribute to host specificity. Mutants defective in each of the pumps were differently affected in their virulence in diverse hosts and the susceptibility to plant-produced antimicrobials was specific for each pump. As discussed in the case of N. gonorrhoeae, this suggests that each of the several efflux pumps encoded in the genome of a given bacterial species may have a different function. This adaptation does not rely exclusively on the extrusion of toxic antimicrobial plant exudates. For instance, salicylic acid, an important signaling molecule produced by plants, induces the expression of the E. chrysanthemi efflux pumps acrAB and emrAB. This indicates that RND efflux pumps are relevant elements mediating bacteria/plant interactions at different levels that include the response to toxic compounds, host specificity and interspecies signal trafficking. This functional role is not confined to plant-infective bacteria. Mutants of the mutualistic symbiont Rhizobium etli lacking the RmrAB efflux pump form fewer nodules on its host Phaseolus vulgaris than the corresponding wild-type strain. Similarly, the SmeAB efflux pump plays an important role in the nodulation competitiveness in Sinorhizobium meliloti. The effect of efflux pumps on plant–bacteria interactions can be host-specific. For instance, BdeAB from Bradyrhizobium japonicum is needed for the symbiotic nitrogen-fixation activity on soybean, but not on other host plants such as mung bean and cowpea.

THE ROLE OF EFFLUX PUMPS IN BACTERIAL VIRULENCE

From a clinical point of view, antibiotic resistance could be considered as a colonization factor since only those organisms surviving within a treated patient will be able to cause an infection. However, in this section we would like to address the direct role that RND efflux pumps play in the virulence of different human pathogens. As mentioned in a previous section, the expression of different RND efflux pumps is triggered by human-produced compounds, and they contribute to the colonization of different environments in the human host. Although the role of efflux pumps on virulence has been studied for several organism, only in a few cases comprehensive studies including different systems from a single bacterial species have been performed. Below we discuss some of these examples

Vibrio cholerae RND EFFLUX PUMPS AND VIRULENCE

Vibrio cholerae possesses six different operons encoding for RND-type efflux systems: vexAB, vexCD (breAB), vexEF, vexGH, vexIJK, and vexLM. While different RND efflux systems often share an OMP, it is rather common that operons encode for a cognate OMP for each system (Figure 2). In the case of V. cholerae, it seems that all six different RND efflux systems operate with the same OMP, encoded by the tolC gene.

During the course of V. cholerae infections, bacteria colonize primarily the small intestine, where they penetrate the mucus lining coating the intestinal epithelium. In addition to factors produced by the innate immune system, the intestinal environment is rich in substances such as bile salts and organic acids that are capable of inhibiting bacterial growth. Predictably, four V. cholerae RND efflux systems have been implicated in in vitro resistance to bile salts and detergents similar to detergent-like molecules the organism is likely to encounter during colonization of the intestinal epithelium.

Susceptibility studies with single and multiple mutant combinations revealed that VexB has broad substrate specificity and that it is the primary RND efflux system responsible for resistance to bile salts in vitro. VexD, VexK, and VexH have also been implied in resistance to bile salts, which denotes redundancy among the different RND efflux systems. Moreover, the expression of vexD is induced in the presence of bile salts. The VexK and VexH contribution to bile salts resistance is only evident in a ΔvexBD double mutant background, which suggests a supportive role for VexK and VexH. However, as point out, this hierarchy might be limited to their in vitro experimental conditions. In fact, the increasing attenuation levels displayed by combination mutants in in vivo colonization experiments (ΔvexBDK ΔvexBDH ΔvexBDHK < ΔRND), suggest that VexH plays a more relevant role than VexK during the infection process.

RND efflux systems are also required for optimal expression of the genes encoding for two of the most important V. cholerae virulence factors: cholera toxin (CT) and the toxin-coregulated pilus (TCP). A ΔRND mutant exhibited decreased transcription of the tcpA and toxT genes, the latter encoding for a transcriptional activator responsible for transcription of the genes encoding for CT, and a concomitant decrease in CT and TCP production. While VexB is able to complement this phenotype, a vexBDHK still exhibits a decrease in CT and TCP, thus suggesting a role for VexM and VexF in virulence factor production.

The mechanism through which the V. cholerae RND efflux systems modulate the production of virulence factors has not been elucidated. However, it has been proposed that deletion of systems with redundant functions could lead to the accumulation of a low molecular weight molecule that normally functions as a negative effector molecule involved in fine-tuning the expression of the affected virulence factors. V. cholerae inhabits aquatic environments where it normally grows associated with zooplankton or egg masses. It is possible that some of the RND efflux systems have dedicated functions specific to this portion of the organism’s life cycle. This may be particularly true for VexM and VexF, for which no function in resistance to bile salts and antimicrobials has been identified to date.

Mycobacterium tuberculosis RND EFFLUX PUMPS AND VIRULENCE

The M. tuberculosis genome possesses 13 different genes encoding for RND proteins. Several domains in these proteins are unique to mycobacteria and are thus designated as MmpL (Mycobacterial membrane protein Large). Four mmpL genes appear to be in operons also containing an mmpS gene. The latter are predicted to encode for proteins equivalent to the MFPs in other bacterial RND systems.

In spite of the documented M. tuberculosis resistance against first and second line antimicrobial therapy, none of the RND systems have been associated with antibiotic efflux to date, the only possible exception being MmpL7, which is capable of conferring isoniazid resistance when overexpressed in Mycobacterium smegmatis. Moreover, deletion mutants created in 11 mmpL genes failed to exhibit significantly altered drug susceptibility in M. tuberculosis.

The primary role of most MmpL proteins appears to be the transport of lipids to be incorporated on the cell envelope. The complex mycobacterial cell wall is composed of peptidoglycan, arabinogalactan, and mycolic acids, the surface of which is covered by non-covalently associated lipids that include trehalose monomycolate (TMM), trehalose dimycolate (TDM), sulfolipids, phenolic glycolipids, and phthiocerol dimycocerosates (PDIMs; ). These lipids play important roles in protection against host-derived toxic molecules, bear an immunomodulatory activity and contribute to M. tuberculosis pathogenicity. Lipid transport functions have been ascribed to MmpL3, MmpL7, and MmpL8, and in some cases deletion mutants have demonstrated the contribution of additional MmpL proteins to host survival and pathogenicity.

The inability to create an mmpL3 deletion mutant combined with its absence in transposon mutant collections suggests that this gene is essential to M. tuberculosis. A recent study aimed at identifying the target of a novel M. tuberculosis antibiotic found data that suggests that MmpL3 transports TMM out of the cell and that its inhibition prevents the incorporation of de novo-synthesized mycolic acids into the cell envelope.

MmpL7 is required for PDIM transport to the cell surface and was the first MmpL protein implicated in lipid transport in M. tuberculosis. In addition, MmpL7 appears to function as a scaffold for the PpsE polyketide synthase required for the final step of phthiocerol synthesis, thus coupling transport and synthesis. At least two different studies have determined that mmpL7 mutants display an attenuation phenotype in murine virulence models. MmpL8 has been implicated in the transport of the SL-N, a precursor of the SL-1 sulfolipid, with a similar mechanism to that of MmpL7 where synthesis and transport appear to be coupled. mmpL8 mutants also display attenuated lethality in murine virulence models.

determined that an mmpL4 mutant has both impaired growth kinetics and impaired lethality in a virulence murine model. The same study determined that while an mmpL11 mutant shows a growth pattern similar to that of the wild-type during the active growth phase, the mutant is attenuated during the course of chronic infections in an in vivo model. No substrate has been identified for these transporters. A role in heme uptake has been recently proposed for MmpL11 and such a function would be in line with the attenuated virulence phenotype observed with an mmpL11 mutant. Furthermore, a role in extrusion of host-derived antimicrobials similar to that observed for V. cholerae RND efflux systems cannot be ruled out for those MmpL proteins that appear to be involved in the M. tuberculosis infection process.

Helicobacter pylori RND EFFLUX PUMPS AND VIRULENCE

The gastric colonizer Helicobacter pylori possesses three different operons encoding for RND efflux systems. Over the years the systems have received different nomenclatures that may often lead to confusion when revising the literature: hp0605–hp0607 is also referred to as hefABC; hp0969–hp0971 was originally denominated as hefFDE and is currently known as cznABC; finally, the system encoded by hp1329–hp1327 was originally named hefIHG and currently hp1329 and hp1328 are known as czcA and czcB, respectively, while hp1327 is known as crdB.

initially assessed in vitro and in vivo expression profiles of each system as well as the individual contribution to intrinsic antibiotic susceptibility. The study revealed that hp0607 (hefC) and hp0969 (hefF) are expressed both in in vivo and in vitro, while hp1329 (hefI) is only expressed in vivo. Knockouts in each system failed to identify a contribution to intrinsic antibiotic susceptibility with 19 different compounds. However, overexpression of selected components has been associated with antibiotic resistance and different studies revisiting the contribution of each system to antibiotic susceptibility determined that hp0607 (hefC) and hp0605 (hefA) are involved in intrinsic antibiotic resistance to diverse antibiotics.

H. pylori is exposed to bile salts resulting from reflux into the human stomach; bile salts have an inhibitory effect on H. pylori growth, yet the ability to thrive in the presence of a bile gradient suggests that this organism has bile resistance mechanisms in place. HefC was recently found to play a role in resistance to bile salts and ceragenins (synthetic bile salt derivatives with antimicrobial activity; ). A hefC mutant exhibited increased susceptibility to deoxycholate, cholate, glycodeoxycholate, taurodeoxycholate, taurocholate and to ceragenin 11(CSA 11); while no changes in susceptibility were observed with mutants in the other two efflux systems. Moreover, HefC appears to have substrate specificity for bile salts, since no change in susceptibility was observed with detergents. Although direct efflux of bile salts through HefC has not been experimentally demonstrated yet, it is likely that this system contributes to H. pylori successful colonization of bile-containing environments.

During the course of gastric colonization, H. pylori is exposed to additional environmental stresses, including low pH gradients (4.0–6.0) and acid shock. Acidic environments impact the bioavailability of metals like iron and nickel, which play an essential role in bacterial metabolism. In addition, environmental metal fluctuations are expected to arise from damaged epithelium and diffusion from ingested food. Maintaining a cytoplasmic metal homeostasis is crucial to bacteria, as excessive concentrations can lead to severe cellular damage. The other two H. pylori RND efflux systems are involved in metal efflux.

The system encoded by hp1327–1329 (crdB, czcB, and czcA) constitutes a novel copper efflux pump. Expression of hp1329 is induced in the presence of copper and growth of hp1327 and hp1328 mutants is inhibited in the presence of this metal. The same study found that expression of hp1326 (renamed as crdA), encoding for a secreted protein, is strongly induced in the presence of copper and growth of an hp1326 mutant was also impaired in the presence of copper. hp1326 is transcribed as a monocistronic unit, but is believed to constitute a copper resistance system along with hp1327–1329. A follow up study revealed that copper-mediated expression of hp1326 requires the CrdRS two-component system; the study did not address expression of hp1327–1229. Mutants lacking the CrdRS system are unable to colonize the stomach of mice. This suggests that hp1326 and hp1327–1329 might play an important role during the infective process of H. pylori.

The RND efflux system encoded by hp0969–0971 (renamed as cznABC) has been implicated in cadmium, zinc, and nickel resistance. showed growth inhibition of individual mutants in the presence of these metals. The H. pylori urease, a nickel-containing enzyme, is an essential colonization factor that enables survival in acidic conditions. Urease activity and expression is regulated in response to nickel availability, accordingly, cznC and cznA mutants exhibited enhanced urease activity. The authors propose that the cznABC system plays an important role in fine-tuning urease activity, as nickel efflux reduces activity, while cadmium and zinc efflux prevents inhibition of this enzyme. High urea concentrations are toxic at neutral pH, therefore, untimely activation of this enzyme resulting from perturbations in metals homeostasis can be detrimental to the cell. The inability of cznA, cznB, and cznC mutants to achieve gastric colonization in a gerbil animal model and the failure of a cznA mutant to survive in acidic conditions might be linked to urease activity.

EFFLUX PUMPS AND GLOBAL BACTERIAL PHYSIOLOGY

One of the putative functions of RND efflux pumps is detoxification from detrimental intermediates derived from bacterial metabolism. Studies on this subject have been mainly performed using mutants that overproduce RND efflux pumps. It is conceivable that overexpression of these elements might cause a metabolic burden on bacterial populations. Indeed, different publications have shown that overproduction of RND efflux pumps may impact bacterial physiology. Moreover, the uncontrolled production of these elements can affect the ability of pathogenic bacteria to infect experimental animal models, seriously impairing their virulence.

The energy expenditure required to constantly maintain the activity of an efflux pump could lead to a fitness reduction upon overproduction of these elements. However, our group has recently shown that overproduction of the P. aeruginosa MexEF-OprN efflux system does not produce a fitness cost as measured in classical competition tests, although it alters several physiological aspects, including elements relevant for P. aeruginosa virulence such as Type III and Type VI secretion. Notably, this effect is specific to each pump and might be associated to their functional role, as overexpression of either MexAB-OprM of MexXY does not produce the same effect.

As mentioned before, efflux pumps might be involved in the elimination of endogenous toxic compounds. The P. aeruginosa MexGHI-OpmD efflux system might be implicated in the extrusion of anthranilate, a toxic intermediate of the Pseudomonas quinolone signal (PQS) synthetic pathway, whereas MexEF-OprN extrudes kynurenine, another intermediate in the same pathway. A recent study has shown that kynurenine and its derivatives have relevant effects in different human diseases, including modulation of the activation of glutamate and nicotinic receptors, the modification of the immune response in situations of inflammation and infection, and the generation and removal of reactive oxygen species. Any potential impact that the constant extrusion of kynurenine by a MexEF-OprN overexpression mutant may have on the pathogenic behavior of P. aeruginosa remains to be established.

Pseudomonas quinolone signal is one of the quorum sensing (QS) signals produced by P. aeruginosa. Strains overexpressing MDR efflux pumps capable of extruding QS signals or their intermediates are likely to be impaired in the QS response. Indeed, overexpression of MexEF-OprN impairs the QS response of P. aeruginosa. Previous studies also showed that MexAB-OprM likely extrudes the 3O12-HSL QS signal, and that overproduction of this efflux pump reduced the expression of selected QS-regulated genes. The P. aeruginosa QS regulon comprises approximately 5% of this organism’s genome; including several genes involved in virulence. Expression of some of these genes might be energetically costly. However, once the QS signals reach a specific threshold, expression of the regulon is maintained. It has been suggested that being signal-blind can be a good adaptive strategy to avoid this energetic burden. Whether the efflux pump-mediated extrusion of QS signals may be beneficial to P. aeruginosa under specific conditions remains to be determined.

Efflux pumps may also compensate for the effects that other bacterial elements may have on the organism. This might be the case of C. jejuni, a leading cause of food-borne enterocolitis worldwide. As an intestinal pathogen this bacterium must overcome the antimicrobial effects of the bile salts secreted into the intestinal tract. The RND-type efflux pump CmeABC confers resistance to a broad range of antibacterial substances including bile salts, fatty acids, and detergents. On the other hand, it has been demonstrated that the type VI secretion system (T6SS) plays a key role in the colonization of the intestinal tract. The activation of the T6SS may enable bile salts to enter inside the bacterium through the open secretion channel; and this can compromise bacterial viability and infective capability. Bile salts trigger the expression of the CmeABC efflux pump; which extrudes the bile salts immediately outside the cell thus alleviating the entrance through the T6SS. The functional interaction between the T6SS and CmeABC might be crucial for intestinal colonization by C. jejuni, thus playing a key role in the virulence of this bacterial pathogen.

Given the integration of RND efflux systems in bacterial metabolic networks, it is not surprising that their regulation is also incorporated in global regulatory networks. Global regulators such as MarA, RamA, and SoxS can activate the expression of efflux pumps such as AcrAB-TolC in E. coli and in additional Enterobacteriaceae. Similarly, the pleiotropic regulator MgrA controls autolysis, virulence, biofilm formation, and efflux pump activity in Staphylococcus aureus. The control of efflux pumps by this global regulator is specific for each pump. Increased expression of mgrA in vivo in a subcutaneous abscess model upregulates expression of the norB and tet38 efflux pumps, whereas expression of norA and norC is downregulated. The relevance of these pumps for the in vivo growth of S. aureus has been studied; norB and tet38 defective mutants present a growth defect in a mice abscess model and the phenotype was not attributable to a staphylococcal stress response.

MexT, the transcriptional activator of MexEF-OprN in P. aeruginosa (Figure 2), constitutes another example of global regulation. MexT regulates the expression of several P. aeruginosa genes. A portion of this regulation is mediated by the activity of the pump through the extrusion of a precursor of the PQS QS signal, and the concomitant impairment of the QS response. However, the expression of other genes is directly regulated by MexT. A recent study demonstrated that MexT functions as a redox-responsive regulator, indicating that it might be involved in controlling cellular redox homeostasis. The fact that a local transcriptional regulator of an efflux pump behaves as a global regulator further supports the involvement of these elements in general processes of bacterial physiology and not simply as a response to the presence of antibiotics in the environment.

CONCLUDING REMARKS

The emergence of antibiotic resistance in bacterial human pathogens is a very recent process in the evolutionary timescale. It is often assumed that resistance genes have been mainly originated in antibiotic producers where they play a detoxification role. However, in the few cases where the origin of resistance genes has been tracked, the original hosts are not antibiotic producers. The QnrA gene from Shewanella algae constitutes a prime example, as it confers resistance to quinolones, which are synthetic antibiotics. This indicates that, at least in some cases, antibiotic resistance would be an emergent function that has been recently selected due to the use of antibiotics for treating infections. As we have seen in this review, MDR efflux pumps also fall within this category, since they exhibit multiple functions relevant to bacterial physiology in addition to mediating antibiotic resistance. A complete understanding of these functions is important in order to define the networks that connect antibiotic resistance with other basic physiological processes, both during the course of infections and in natural, non-clinical ecosystems.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References 167

  1. 1.

    Aendekerk S. Diggle S. P. Song Z. Hoiby N. Cornelis P. Williams P. (2005 ). The MexGHI-OpmD multidrug efflux pump controls growth, antibiotic susceptibility and virulence in Pseudomonas aeruginosa via 4-quinolone-dependent cell-to-cell communication. Microbiology 151 1113–1125

    Not in our library10.1099/mic.0.27631-0

  2. 2.

    Aendekerk S. Ghysels B. Cornelis P. Baysse C. (2002 ). Characterization of a new efflux pump, MexGHI-OpmD, from Pseudomonas aeruginosa that confers resistance to vanadium. Microbiology 148 2371–2381

    Not in our library10.1099/00221287-148-8-2371

  3. 3.

    Alguel Y. Meng C. Teran W. Krell T. Ramos J. L. Gallegos M. T. (2007 ). Crystal structures of multidrug binding protein TtgR in complex with antibiotics and plant antimicrobials. J. Mol. Biol. 369 829–840

    Not in our library10.1016/j.jmb.2007.03.062

  4. 4.

    Alonso A. Morales G. Escalante R. Campanario E. Sastre L. Martinez J. L. (2004 ). Overexpression of the multidrug efflux pump SmeDEF impairs Stenotrophomonas maltophilia physiology. J. Antimicrob. Chemother. 53 432–434

    Not in our library10.1093/jac/dkh074

  5. 5.

    Alonso A. Rojo F. Martinez J. L. (1999 ). Environmental and clinical isolates of Pseudomonas aeruginosa show pathogenic and biodegradative properties irrespective of their origin. Environ. Microbiol. 1 421–430

    Not in our library10.1046/j.1462-2920.1999.00052.x

  6. 6.

    Alonso A. Sanchez P. Martinez J. L. (2001 ). Environmental selection of antibiotic resistance genes. Environ. Microbiol. 3 1–9

    Not in our library10.1046/j.1462-2920.2001.00161.x

  7. 7.

    Andam C. P. Fournier G. P. Gogarten J. P. (2011 ). Multilevel populations and the evolution of antibiotic resistance through horizontal gene transfer. FEMS Microbiol. Rev. 35 756–767

    Not in our library10.1111/j.1574-6976.2011.00274.x

  8. 8.

    Andersson D. I. Hughes D. (2010 ). Antibiotic resistance and its cost: is it possible to reverse resistance? Nat. Rev. Microbiol. 8 260–271

    Not in our library10.1038/nrmicro2319

  9. 9.

    Baquero F. (2004 ). From pieces to patterns: evolutionary engineering in bacterial pathogens. Nat. Rev. Microbiol. 2 510–518

    Not in our library10.1038/nrmicro909

  10. 10.

    Baquero F. Alvarez-Ortega C. Martinez J. L. (2009 ). Ecology and evolution of antibiotic resistance. Environ. Microbiol. Rep. 1 469–476

    Not in our library10.1111/j.1758-2229.2009.00053.x

  11. 11.

    Barabote R. D. Johnson O. L. Zetina E. San Francisco S. K. Fralick J. A San Francisco M. J. (2003 ). Erwinia chrysanthemi tolC is involved in resistance to antimicrobial plant chemicals and is essential for phytopathogenesis. J. Bacteriol. 185 5772–5778

    Not in our library10.1128/jb.185.19.5772-5778.2003

  12. 12.

    Benveniste R. Davies J. (1973 ). Aminoglycoside antibiotic-inactivating enzymes in actinomycetes similar to those present in clinical isolates of antibiotic-resistant bacteria. Proc. Natl. Acad. Sci. U.S.A. 70 2276–2280

    Not in our library10.1073/pnas.70.8.2276

  13. 13.

    Bidlack J. E. Silverman P. M. (2004 ). An active type IV secretion system encoded by the F plasmid sensitizes Escherichia coli to bile salts. J. Bacteriol. 186 5202–5209

    Not in our library10.1128/jb.186.16.5202-5209.2004

  14. 14.

    Bijlsma J. J. Lie A. L. M. Nootenboom I. C. Vandenbroucke-Grauls C. M. Kusters J. G. (2000 ). Identification of loci essential for the growth of Helicobacter pylori under acidic conditions. J. Infect. Dis. 182 1566–1569

    Not in our library10.1086/315855

  15. 15.

    Bina J. E. Alm R. A. Uria-Nickelsen M. Thomas S. R. Trust T. J. Hancock R. E. (2000 ). Helicobacter pylori uptake and efflux: basis for intrinsic susceptibility to antibiotics in vitro. Antimicrob. Agents Chemother. 44 248–254

    Not in our library10.1128/aac.44.2.248-254.2000

  16. 16.

    Bina X. R. Provenzano D. Nguyen N. Bina J. E. (2008 ). Vibrio cholerae RND family efflux systems are required for antimicrobial resistance, optimal virulence factor production, and colonization of the infant mouse small intestine. Infect. Immun. 76 3595–3605

    Not in our library10.1128/iai.01620-07

  17. 17.

    Blair J. M. Piddock L. J. (2009 ). Structure, function and inhibition of RND efflux pumps in Gram-negative bacteria: an update. Curr. Opin. Microbiol. 12 512–519

    Not in our library10.1016/j.mib.2009.07.003

  18. 18.

    Burse A. Weingart H. Ullrich M. S. (2004a ). NorM, an Erwinia amylovora multidrug efflux pump involved in in vitro competition with other epiphytic bacteria. Appl. Environ. Microbiol. 70 693–703

    Not in our library10.1128/aem.70.2.693-703.2004

  19. 19.

    Burse A. Weingart H. Ullrich M. S. (2004b ). The phytoalexin-inducible multidrug efflux pump AcrAB contributes to virulence in the fire blight pathogen, Erwinia amylovora. Mol. Plant Microbe Interact. 17 43–54

    Not in our library10.1094/mpmi.2004.17.1.43

  20. 20.

    Caille O. Rossier C. Perron K. (2007 ). A copper-activated two-component system interacts with zinc and imipenem resistance in Pseudomonas aeruginosa. J. Bacteriol. 189 4561–4568

    Not in our library10.1128/jb.00095-07

  21. 21.

    Cerda-Maira F. A. Ringelberg C. S. Taylor R. K. (2008 ). The bile response repressor BreR regulates expression of the Vibrio cholerae breAB efflux system operon. J. Bacteriol. 190 7441–7452

    Not in our library10.1128/jb.00584-08

  22. 22.

    Chung Y. J. Saier M. H. Jr (2001 ). SMR-type multidrug resistance pumps. Curr. Opin. Drug Discov. Dev. 4 237–245

    Not in our library

  23. 23.

    Cole S. T. Brosch R. Parkhill J. Garnier T. Churcher C. Harris D. (1998 ). Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393 537–544

    Not in our library10.1038/31159

  24. 24.

    Converse S. E. Mougous J. D. Leavell M. D. Leary J. A. Bertozzi C. R. Cox J. S. (2003 ). MmpL8 is required for sulfolipid-1 biosynthesis and Mycobacterium tuberculosis virulence. Proc. Natl. Acad. Sci. U.S.A. 100 6121–6126

    Not in our library10.1073/pnas.1030024100

  25. 25.

    Cosson P. Zulianello L. Join-Lambert O. Faurisson F. Gebbie L. Benghezal M. (2002 ). Pseudomonas aeruginosa virulence analyzed in a Dictyostelium discoideum host system. J. Bacteriol. 184 3027–3033

    Not in our library10.1128/jb.184.11.3027-3033.2002

  26. 26.

    Cox J. S. Chen B. Mcneil M. Jacobs W. R. Jr (1999 ). Complex lipid determines tissue-specific replication of Mycobacterium tuberculosis in mice. Nature 402 79–83

    Not in our library10.1038/47042

  27. 27.

    da Silva P. E. Von Groll A. Martin A. Palomino J. C. (2011 ). Efflux as a mechanism for drug resistance in Mycobacterium tuberculosis. FEMS Immunol. Med. Microbiol. 63 1–9

    Not in our library10.1111/j.1574-695x.2011.00831.x

  28. 28.

    Davies J. E. (1997 ). Origins, acquisition and dissemination of antibiotic resistance determinants. Ciba Found. Symp. 207 15–27

    Not in our library

  29. 29.

    Davin-Regli A. Bolla J. M. James C. E. Lavigne J. P. Chevalier J. Garnotel E. (2008 ). Membrane permeability and regulation of drug “influx and efflux” in enterobacterial pathogens. Curr. Drug Targets 9 750–759

    Not in our library10.2174/138945008785747824

  30. 30.

    Deng X. Sun F. Ji Q. Liang H. Missiakas D. Lan L. (2012 ). Expression of multidrug resistance efflux pump gene norA is iron responsive in Staphylococcus aureus. J. Bacteriol. 194 1753–1762

    Not in our library10.1128/jb.06582-11

  31. 31.

    De Rossi E. Ainsa J. A. Riccardi G. (2006 ). Role of mycobacterial efflux transporters in drug resistance: an unresolved question. FEMS Microbiol. Rev. 30 36–52

    Not in our library10.1111/j.1574-6976.2005.00002.x

  32. 32.

    Dieppois G. Ducret V. Caille O. Perron K. (2012 ). The transcriptional regulator CzcR modulates antibiotic resistance and quorum sensing in Pseudomonas aeruginosa. PLoS ONE 7:e38148

    Not in our library10.1371/journal.pone.0038148

  33. 33.

    Ding Y. Onodera Y. Lee J. C. Hooper D. C. (2008 ). NorB, an efflux pump in Staphylococcus aureus MW2, contributes to bacterial fitness in abscesses. J. Bacteriol. 190 7123–7129

    Not in our library10.1128/jb.00655-08

  34. 34.

    Domenech P. Reed M. B Barry C. E. III (2005 ). Contribution of the Mycobacterium tuberculosis MmpL protein family to virulence and drug resistance. Infect. Immun. 73 3492–3501

    Not in our library10.1128/iai.73.6.3492-3501.2005

  35. 35.

    Domenech P. Reed M. B. Dowd C. S. Manca C. Kaplan G Barry C. E. III (2004 ). The role of MmpL8 in sulfatide biogenesis and virulence of Mycobacterium tuberculosis. J. Biol. Chem. 279 21257–21265

    Not in our library10.1074/jbc.m400324200

  36. 36.

    Eastgate J. (2000 ). Erwinia amylovora: the molecular basis of fireblight disease. Mol. Plant Pathol. 1 325–329

    Not in our library10.1046/j.1364-3703.2000.00044.x

  37. 37.

    Eda S. Mitsui H. Minamisawa K. (2011 ). Involvement of the smeAB multidrug efflux pump in resistance to plant antimicrobials and contribution to nodulation competitiveness in Sinorhizobium meliloti. Appl. Environ. Microbiol. 77 2855–2862

    Not in our library10.1128/aem.02858-10

  38. 38.

    Espinosa-Urgel M. Salido A. Ramos J. L. (2000 ). Genetic analysis of functions involved in adhesion of Pseudomonas putida to seeds. J. Bacteriol. 182 2363–2369

    Not in our library10.1128/jb.182.9.2363-2369.2000

  39. 39.

    Evans K. Passador L. Srikumar R. Tsang E. Nezezon J. Poole K. (1998 ). Influence of the MexAB-OprM multidrug efflux system on quorum sensing in Pseudomonas aeruginosa. J. Bacteriol. 180 5443–5447

    Not in our library10.1128/jb.180.20.5443-5447.1998

  40. 40.

    Fajardo A. Linares J. F. Martinez J. L. (2009 ). Towards an ecological approach to antibiotics and antibiotic resistance genes. Clin. Microbiol. Infect. 15(Suppl. 1) 14–16

    Not in our library10.1111/j.1469-0691.2008.02688.x

  41. 41.

    Fargier E. Mac Aogáin M. Mooij M. J. Woods D. F. Morrissey J. P. Dobson A. D. W. (2012 ). MexT functions as a redox-responsive regulator modulating disulfide stress resistance in Pseudomonas aeruginosa. J. Bacteriol. 194 3502–3511

    Not in our library10.1128/jb.06632-11

  42. 42.

    Franke S. Grass G. Nies D. H. (2001 ). The product of the ybdE gene of the Escherichia coli chromosome is involved in detoxification of silver ions. Microbiology 147 965–972

    Not in our library10.1099/00221287-147-4-965

  43. 43.

    Gonzalez-Pasayo R. Martinez-Romero E. (2000 ). Multiresistance genes of Rhizobium etli CFN42. Mol. Plant Microbe Interact. 13 572–577

    Not in our library10.1094/mpmi.2000.13.5.572

  44. 44.

    Grass G. Rensing C. (2001 ). Genes involved in copper homeostasis in Escherichia coli. J. Bacteriol. 183 2145–2147

    Not in our library10.1128/jb.183.6.2145-2147.2001

  45. 45.

    Grkovic S. Brown M. H. Skurray R. A. (2002 ). Regulation of bacterial drug export systems. Microbiol. Mol. Biol. Rev. 66 671–701

    Not in our library10.1128/mmbr.66.4.671-701.2002

  46. 46.

    Haas D. (2006 ). Cost of cell–cell signalling in Pseudomonas aeruginosa: why it can pay to be signal-blind. Nat. Rev. Microbiol. 4 562

    Not in our library10.1038/nrmicro1466-c1

  47. 47.

    Hernandez A. Mate M. J. Sanchez-Diaz P. C. Romero A. Rojo F. Martinez J. L. (2009 ). Structural and functional analysis of SmeT, the repressor of the Stenotrophomonas maltophilia multidrug efflux pump SmeDEF. J. Biol. Chem. 284 14428–14438

    Not in our library10.1074/jbc.m809221200

  48. 48.

    Hernandez A. Ruiz F. M. Romero A. Martinez J. L. (2011a ). The binding of triclosan to SmeT, the repressor of the multidrug efflux pump SmeDEF, induces antibiotic resistance in Stenotrophomonas maltophilia. PLoS Pathog. 7:e1002103

    Not in our library10.1371/journal.ppat.1002103

  49. 49.

    Hernandez A. Sanchez M. B. Martinez J. L. (2011b ). Quinolone resistance: much more than predicted. Front. Microbiol. 2:22

    Not in our library10.3389/fmicb.2011.00022

  50. 50.

    Hirakata Y. Srikumar R. Poole K. Gotoh N. Suematsu T. Kohno S. (2002 ). Multidrug efflux systems play an important role in the invasiveness of Pseudomonas aeruginosa. J. Exp. Med. 196 109–118

    Not in our library10.1084/jem.20020005

  51. 51.

    Hirata K. Suzuki H. Nishizawa T. Tsugawa H. Muraoka H. Saito Y. (2010 ). Contribution of efflux pumps to clarithromycin resistance in Helicobacter pylori. J. Gastroenterol. Hepatol. 25(Suppl. 1) S75–S79

    Not in our library10.1111/j.1440-1746.2009.06220.x

  52. 52.

    Hofmann A. F. Eckmann L. (2006 ). How bile acids confer gut mucosal protection against bacteria. Proc. Natl. Acad. Sci. U.S.A. 103 4333–4334

    Not in our library10.1073/pnas.0600780103

  53. 53.

    Ingavale S. Van Wamel W. Luong T. T. Lee C. Y. Cheung A. L. (2005 ). Rat/MgrA, a regulator of autolysis, is a regulator of virulence genes in Staphylococcus aureus. Infect. Immun. 73 1423–1431

    Not in our library10.1128/iai.73.3.1423-1431.2005

  54. 54.

    Ingavale S. S. Van Wamel W. Cheung A. L. (2003 ). Characterization of RAT, an autolysis regulator in Staphylococcus aureus. Mol. Microbiol. 48 1451–1466

    Not in our library10.1046/j.1365-2958.2003.03503.x

  55. 55.

    Jain M. Cox J. S. (2005 ). Interaction between polyketide synthase and transporter suggests coupled synthesis and export of virulence lipid in M. tuberculosis. PLoS Pathog. 1:e2

    Not in our library10.1371/journal.ppat.0010002

  56. 56.

    Jerse A. E. Sharma N. D. Simms A. N. Crow E. T. Snyder L. A. Shafer W. M. (2003 ). A gonococcal efflux pump system enhances bacterial survival in a female mouse model of genital tract infection. Infect. Immun. 71 5576–5582

    Not in our library10.1128/iai.71.10.5576-5582.2003

  57. 57.

    Johnson P. J. Stringer V. A. Shafer W. M. (2011 ). Off-target gene regulation mediated by transcriptional repressors of antimicrobial efflux pump genes in Neisseria gonorrhoeae. Antimicrob. Agents Chemother. 55 2559–2565

    Not in our library10.1128/aac.00010-11

  58. 58.

    Kitaoka M. Miyata S. T. Unterweger D. Pukatzki S. (2011 ). Antibiotic resistance mechanisms of Vibrio cholerae. J. Med. Microbiol. 60 397–407

    Not in our library10.1099/jmm.0.023051-0

  59. 59.

    Kohler T. Epp S. F. Curty L. K. Pechere J. C. (1999 ). Characterization of MexT, the regulator of the MexE-MexF-OprN multidrug efflux system of Pseudomonas aeruginosa. J. Bacteriol. 181 6300–6305

    Not in our library10.1128/jb.181.20.6300-6305.1999

  60. 60.

    Kohler T. Van Delden C. Curty L. K. Hamzehpour M. M. Pechere J. C. (2001 ). Overexpression of the MexEF-OprN multidrug efflux system affects cell-to-cell signaling in Pseudomonas aeruginosa. J. Bacteriol. 183 5213–5222

    Not in our library10.1128/jb.183.18.5213-5222.2001

  61. 61.

    Koronakis V. Eswaran J. Hughes C. (2004 ). Structure and function of TolC: the bacterial exit duct for proteins and drugs. Annu. Rev. Biochem. 73 467–489

    Not in our library10.1146/annurev.biochem.73.011303.074104

  62. 62.

    Koronakis V. Sharff A. Koronakis E. Luisi B. Hughes C. (2000 ). Crystal structure of the bacterial membrane protein TolC central to multidrug efflux and protein export. Nature 405 914–919

    Not in our library10.1038/35016007

  63. 63.

    Kuroda T. Tsuchiya T. (2009 ). Multidrug efflux transporters in the MATE family. Biochim. Biophys. Acta 1794 763–768

    Not in our library10.1016/j.bbapap.2008.11.012

  64. 64.

    Kutschke A de Jonge B. L. (2005 ). Compound efflux in Helicobacter pylori. Antimicrob. Agents Chemother. 49 3009–3010

    Not in our library10.1128/aac.49.7.3009-3010.2005

  65. 65.

    Lamichhane G. Tyagi S. Bishai W. R. (2005 ). Designer arrays for defined mutant analysis to detect genes essential for survival of Mycobacterium tuberculosis in mouse lungs. Infect. Immun. 73 2533–2540

    Not in our library10.1128/iai.73.4.2533-2540.2005

  66. 66.

    Lee E. H. Shafer W. M. (1999 ). The farAB-encoded efflux pump mediates resistance of gonococci to long-chained antibacterial fatty acids. Mol. Microbiol. 33 839–845

    Not in our library10.1046/j.1365-2958.1999.01530.x

  67. 67.
    Campylobacter jejuni Type VI Secretion System: Roles in Adaptation to Deoxycholic Acid, Host Cell Adherence, Invasion, and In Vivo Colonization · 2012
    No notice
  68. 68.

    Li X. Z. Nikaido H. (2004 ). Efflux-mediated drug resistance in bacteria. Drugs 64 159–204

    Not in our library10.2165/00003495-200464020-00004

  69. 69.

    Li X. Z. Nikaido H. (2009 ). Efflux-mediated drug resistance in bacteria: an update. Drugs 69 1555–1623

    Not in our library10.2165/11317030-000000000-00000

  70. 70.

    Lin J. Akiba M. Sahin O. Zhang Q. (2005a ). CmeR functions as a transcriptional repressor for the multidrug efflux pump CmeABC in Campylobacter jejuni. Antimicrob. Agents Chemother. 49 1067–1075

    Not in our library10.1128/aac.49.3.1067-1075.2005

  71. 71.

    Lin J. Cagliero C. Guo B. Barton Y. W. Maurel M. C. Payot S. (2005b ). Bile salts modulate expression of the CmeABC multidrug efflux pump in Campylobacter jejuni. J. Bacteriol. 187 7417–7424

    Not in our library10.1128/jb.187.21.7417-7424.2005

  72. 72.

    Linares J. F. Lopez J. A. Camafeita E. Albar J. P. Rojo F. Martinez J. L. (2005 ). Overexpression of the multidrug efflux pumps MexCD-OprJ and MexEF-OprN is associated with a reduction of type III secretion in Pseudomonas aeruginosa. J. Bacteriol. 187 1384–1391

    Not in our library10.1128/jb.187.4.1384-1391.2005

  73. 73.

    Linares J. F. Moreno R. Fajardo A. Martinez-Solano L. Escalante R. Rojo F. (2010 ). The global regulator Crc modulates metabolism, susceptibility to antibiotics and virulence in Pseudomonas aeruginosa. Environ. Microbiol. 12 3196–3212

    Not in our library10.1111/j.1462-2920.2010.02292.x

  74. 74.

    Lindemann A. Koch M. Pessi G. Muller A. J. Balsiger S. Hennecke H. (2010 ). Host-specific symbiotic requirement of BdeAB, a RegR-controlled RND-type efflux system in Bradyrhizobium japonicum. FEMS Microbiol. Lett. 312 184–191

    Not in our library10.1111/j.1574-6968.2010.02115.x

  75. 75.

    Liu Z. Q. Zheng P. Y. Yang P. C. (2008 ). Efflux pump gene hefA of Helicobacter pylori plays an important role in multidrug resistance. World J. Gastroenterol. 14 5217–5222

    Not in our library10.3748/wjg.14.5217

  76. 76.

    Loake G. Grant M. (2007 ). Salicylic acid in plant defence-the players and protagonists. Curr. Opin. Plant Biol. 10 466–472

    Not in our library10.1016/j.pbi.2007.08.008

  77. 77.

    Lubelski J. Konings W. N. Driessen A. J. (2007 ). Distribution and physiology of ABC-type transporters contributing to multidrug resistance in bacteria. Microbiol. Mol. Biol. Rev. 71 463–476

    Not in our library10.1128/mmbr.00001-07

  78. 78.

    Luong T. T. Dunman P. M. Murphy E. Projan S. J. Lee C. Y. (2006 ). Transcription profiling of the mgrA regulon in Staphylococcus aureus. J. Bacteriol. 188 1899–1910

    Not in our library10.1128/jb.188.5.1899-1910.2006

  79. 79.

    Ma D. Alberti M. Lynch C. Nikaido H. Hearst J. E. (1996 ). The local repressor AcrR plays a modulating role in the regulation of acrAB genes of Escherichia coli by global stress signals. Mol. Microbiol. 19 101–112

    Not in our library10.1046/j.1365-2958.1996.357881.x

  80. 80.

    Ma D. Cook D. N. Alberti M. Pon N. G. Nikaido H. Hearst J. E. (1995 ). Genes acrA and acrB encode a stress-induced efflux system of Escherichia coli. Mol. Microbiol. 16 45–55

    Not in our library10.1111/j.1365-2958.1995.tb02390.x

  81. 81.

    Maggiorani Valecillos A. Rodriguez Palenzuela P. Lopez-Solanilla E. (2006 ). The role of several multidrug resistance systems in Erwinia chrysanthemi pathogenesis. Mol. Plant Microbe Interact. 19 607–613

    Not in our library10.1094/mpmi-19-0607

  82. 82.

    Martin R. G. Bartlett E. S. Rosner J. L. Wall M. E. (2008 ). Activation of the Escherichia coli marA/soxS/rob regulon in response to transcriptional activator concentration. J. Mol. Biol. 380 278–284

    Not in our library10.1016/j.jmb.2008.05.015

  83. 83.

    Martinez J. L. (2008 ). Antibiotics and antibiotic resistance genes in natural environments. Science 321 365–367

    Not in our library10.1126/science.1159483

  84. 84.

    Martinez J. L. (2009a ). Environmental pollution by antibiotics and by antibiotic resistance determinants. Environ. Pollut. 157 2893–2902

    Not in our library10.1016/j.envpol.2009.05.051

  85. 85.

    Martinez J. L. (2009b ). The role of natural environments in the evolution of resistance traits in pathogenic bacteria. Proc. R. Soc. Lond. B Biol. Sci. 276 2521–2530

    Not in our library10.1098/rspb.2009.0320

  86. 86.

    Martinez J. L. Baquero F. (2002 ). Interactions among strategies associated with bacterial infection: pathogenicity, epidemicity, and antibiotic resistance. Clin. Microbiol. Rev. 15 647–679

    Not in our library10.1128/cmr.15.4.647-679.2002

  87. 87.

    Martinez J. L. Baquero F. Andersson D. I. (2007 ). Predicting antibiotic resistance. Nat. Rev. Microbiol. 5 958–965

    Not in our library10.1038/nrmicro1796

  88. 88.

    Martinez J. L. Baquero F. Andersson D. I. (2011 ). Beyond serial passages: new methods for predicting the emergence of resistance to novel antibiotics. Curr. Opin. Pharmacol. 11 439–445

    Not in our library10.1016/j.coph.2011.07.005

  89. 89.

    Martinez J. L. Delgado-Iribarren A. Baquero F. (1990 ). Mechanisms of iron acquisition and bacterial virulence. FEMS Microbiol. Rev. 6 45–56

    Not in our library10.1111/j.1574-6968.1990.tb04085.x

  90. 90.

    Martinez J. L. Fajardo A. Garmendia L. Hernandez A. Linares J. F. Martinez-Solano L. (2009a ). A global view of antibiotic resistance. FEMS Microbiol. Rev. 33 44–65

    Not in our library10.1111/j.1574-6976.2008.00142.x

  91. 91.

    Martinez J. L. Sanchez M. B. Martinez-Solano L. Hernandez A. Garmendia L. Fajardo A. (2009b ). Functional role of bacterial multidrug efflux pumps in microbial natural ecosystems. FEMS Microbiol. Rev. 33 430–449

    Not in our library10.1111/j.1574-6976.2008.00157.x

  92. 92.

    Martinez J. L. Rojo F. (2011 ). Metabolic regulation of antibiotic resistance. FEMS Microbiol. Rev. 35 768–789

    Not in our library10.1111/j.1574-6976.2011.00282.x

  93. 93.
    Genomic analysis reveals the major driving forces of bacterial life in the rhizosphere · 2007
    No notice
  94. 94.

    Mcknight S. L. Iglewski B. H. Pesci E. C. (2000 ). The Pseudomonas quinolone signal regulates rhl quorum sensing in Pseudomonas aeruginosa. J. Bacteriol. 182 2702–2708

    Not in our library10.1128/jb.182.10.2702-2708.2000

  95. 95.

    Mercante A. D. Jackson L. Johnson P. J. Stringer V. A. Dyer D. W. Shafer W. M. (2012 ). MpeR regulates the mtr efflux locus in Neisseria gonorrhoeae and modulates antimicrobial resistance by an iron-responsive mechanism. Antimicrob. Agents Chemother. 56 1491–1501

    Not in our library10.1128/aac.06112-11

  96. 96.

    Meyer-Rosberg K. Scott D. R. Rex D. Melchers K. Sachs G. (1996 ). The effect of environmental pH on the proton motive force of Helicobacter pylori. Gastroenterology 111 886–900

    Not in our library10.1016/s0016-5085(96)70056-2

  97. 97.

    Mine T. Morita Y. Kataoka A. Mizushima T. Tsuchiya T. (1999 ). Expression in Escherichia coli of a new multidrug efflux pump, MexXY, from Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 43 415–417

    Not in our library10.1128/aac.43.2.415

  98. 98.

    Murakami S. Nakashima R. Yamashita E. Matsumoto T. Yamaguchi A. (2006 ). Crystal structures of a multidrug transporter reveal a functionally rotating mechanism. Nature 443 173–179

    Not in our library10.1038/nature05076

  99. 99.

    Murakami S. Nakashima R. Yamashita E. Yamaguchi A. (2002 ). Crystal structure of bacterial multidrug efflux transporter AcrB. Nature 419 587–593

    Not in our library10.1038/nature01050

  100. 100.

    Nakashima R. Sakurai K. Yamasaki S. Nishino K. Yamaguchi A. (2011 ). Structures of the multidrug exporter AcrB reveal a proximal multisite drug-binding pocket. Nature 480 565–569

    Not in our library10.1038/nature10641

  101. 101.

    Neyfakh A. A. (1997 ). Natural functions of bacterial multidrug transporters. Trends Microbiol. 5 309–313

    Not in our library10.1016/s0966-842x(97)01064-0

  102. 102.

    Neyrolles O. Guilhot C. (2011 ). Recent advances in deciphering the contribution of Mycobacterium tuberculosis lipids to pathogenesis. Tuberculosis 91 187–195

    Not in our library10.1016/j.tube.2011.01.002

  103. 103.

    Nies D. H. (2003 ). Efflux-mediated heavy metal resistance in prokaryotes. FEMS Microbiol. Rev. 27 313–339

    Not in our library10.1016/s0168-6445(03)00048-2

  104. 104.

    Nikaido E. Yamaguchi A. Nishino K. (2008 ). AcrAB multidrug efflux pump regulation in Salmonella enterica serovar Typhimurium by RamA in response to environmental signals. J. Biol. Chem. 283 24245–24253

    Not in our library10.1074/jbc.m804544200

  105. 105.

    Nikaido H. (2009 ). Multidrug resistance in bacteria. Annu. Rev. Biochem. 78 119–146

    Not in our library10.1146/annurev.biochem.78.082907.145923

  106. 106.

    Nikaido H. (2011 ). Structure and mechanism of RND-type multidrug efflux pumps. Adv. Enzymol. Relat. Areas Mol. Biol. 77 1–60

    Not in our library10.1002/9780470920541.ch1

  107. 107.

    Nikaido H. Takatsuka Y. (2009 ). Mechanisms of RND multidrug efflux pumps. Biochim. Biophys. Acta 1794 769–781

    Not in our library10.1016/j.bbapap.2008.10.004

  108. 108.

    Olivares J. Alvarez-Ortega C. Linares J. F. Rojo F. Kohler T. Martinez J. L. (2012 ). Overproduction of the multidrug efflux pump MexEF-OprN does not impair Pseudomonas aeruginosa fitness in competition tests, but produces specific changes in bacterial regulatory networks. Environ. Microbiol. 14 1968–1981

    Not in our library10.1111/j.1462-2920.2012.02727.x

  109. 109.

    Palumbo J. D. Kado C. I. Phillips D. A. (1998 ). An isoflavonoid-inducible efflux pump in Agrobacterium tumefaciens is involved in competitive colonization of roots. J. Bacteriol. 180 3107–3113

    Not in our library10.1128/jb.180.12.3107-3113.1998

  110. 110.

    Panthel K. Dietz P. Haas R. Beier D. (2003 ). Two-component systems of Helicobacter pylori contribute to virulence in a mouse infection model. Infect. Immun. 71 5381–5385

    Not in our library10.1128/iai.71.9.5381-5385.2003

  111. 111.

    Pao S. S. Paulsen I. T. Saier M. H. Jr (1998 ). Major facilitator superfamily. Microbiol. Mol. Biol. Rev. 62 1–34

    Not in our library10.1128/mmbr.62.1.1-34.1998

  112. 112.

    Pasca M. R. Guglierame P. De Rossi E. Zara F. Riccardi G. (2005 ). mmpL7 gene of Mycobacterium tuberculosis is responsible for isoniazid efflux in Mycobacterium smegmatis. Antimicrob. Agents Chemother. 49 4775–4777

    Not in our library10.1128/aac.49.11.4775-4777.2005

  113. 113.

    Paulsen I. T. (2003 ). Multidrug efflux pumps and resistance: regulation and evolution. Curr. Opin. Microbiol. 6 446–451

    Not in our library10.1016/j.mib.2003.08.005

  114. 114.

    Paulsen I. T. Chen J. Nelson K. E. Saier M. H. Jr (2001 ). Comparative genomics of microbial drug efflux systems. J. Mol. Microbiol. Biotechnol. 3 145–150

    Not in our library

  115. 115.

    Pearson J. P. Van Delden C. Iglewski B. H. (1999 ). Active efflux and diffusion are involved in transport of Pseudomonas aeruginosa cell-to-cell signals. J. Bacteriol. 181 1203–1210

    Not in our library10.1128/jb.181.4.1203-1210.1999

  116. 116.

    Perez A. Poza M. Aranda J. Latasa C. Medrano F. J. Tomas M. (2012 ). Effect of the transcriptional activators SoxS, RobA and RamA on expression of the multidrug efflux pump AcrAB-TolC in Enterobacter cloacae. Antimicrob. Agents Chemother. 56 6256–6266

    Not in our library10.1128/aac.01085-12

  117. 117.

    Piddock L. J. (2006a ). Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria. Clin. Microbiol. Rev. 19 382–402

    Not in our library10.1128/cmr.19.2.382-402.2006

  118. 118.

    Piddock L. J. (2006b ). Multidrug-resistance efflux pumps – not just for resistance. Nat. Rev. Microbiol. 4 629–636

    Not in our library10.1038/nrmicro1464

  119. 119.

    Poirel L. Rodriguez-Martinez J. M. Mammeri H. Liard A. Nordmann P. (2005 ). Origin of plasmid-mediated quinolone resistance determinant QnrA. Antimicrob. Agents Chemother. 49 3523–3525

    Not in our library10.1128/aac.49.8.3523-3525.2005

  120. 120.

    Poole K. (2004 ). “Efflux pumps,” in Pseudomonas, ed Ramos J.-L. (New York: Kluwer Academic/Plenum Publisher) 636–641

    Not in our library

  121. 121.

    Poole K. (2005 ). Efflux-mediated antimicrobial resistance. J. Antimicrob. Chemother. 56 20–51

    Not in our library10.1093/jac/dki171

  122. 122.

    Poole K. (2007 ). Efflux pumps as antimicrobial resistance mechanisms. Ann. Med. 39 162–176

    Not in our library10.1080/07853890701195262

  123. 123.

    Poole K. Gotoh N. Tsujimoto H. Zhao Q. Wada A. Yamasaki T. (1996 ). Overexpression of the mexC-mexD-oprJ efflux operon in nfxB-type multidrug-resistant strains of Pseudomonas aeruginosa. Mol. Microbiol. 21 713–724

    Not in our library10.1046/j.1365-2958.1996.281397.x

  124. 124.

    Pumbwe L. Skilbeck C. A. Nakano V. Avila-Campos M. J. Piazza R. M. Wexler H. M. (2007 ). Bile salts enhance bacterial co-aggregation, bacterial-intestinal epithelial cell adhesion, biofilm formation and antimicrobial resistance of Bacteroides fragilis. Microb. Pathog. 43 78–87

    Not in our library10.1016/j.micpath.2007.04.002

  125. 125.

    Ramos J. L. Duque E. Gallegos M. T. Godoy P. Ramos-Gonzalez M. I. Rojas A. (2002 ). Mechanisms of solvent tolerance in gram-negative bacteria. Annu. Rev. Microbiol. 56 743–768

    Not in our library10.1146/annurev.micro.56.012302.161038

  126. 126.

    Ravirala R. S. Barabote R. D. Wheeler D. M. Reverchon S. Tatum O. Malouf J. (2007 ). Efflux pump gene expression in Erwinia chrysanthemi is induced by exposure to phenolic acids. Mol. Plant Microbe Interact. 20 313–320

    Not in our library10.1094/mpmi-20-3-0313

  127. 127.

    Reidl J. Klose K. E. (2002 ). Vibrio cholerae and cholera: out of the water and into the host. FEMS Microbiol. Rev. 26 125–139

    Not in our library10.1111/j.1574-6976.2002.tb00605.x

  128. 128.

    Rektorschek M. Weeks D. Sachs G. Melchers K. (1998 ). Influence of pH on metabolism and urease activity of Helicobacter pylori. Gastroenterology 115 628–641

    Not in our library10.1016/s0016-5085(98)70142-8

  129. 129.

    Rosenberg E. Y. Bertenthal D. Nilles M. L. Bertrand K. P. Nikaido H. (2003 ). Bile salts and fatty acids induce the expression of Escherichia coli AcrAB multidrug efflux pump through their interaction with Rob regulatory protein. Mol. Microbiol. 48 1609–1619

    Not in our library10.1046/j.1365-2958.2003.03531.x

  130. 130.

    Ruiz-Diez B. Sanchez P. Baquero F. Martinez J. L. Navas A. (2003 ). Differential interactions within the Caenorhabditis elegans–Pseudomonas aeruginosa pathogenesis model. J. Theor. Biol. 225 469–476

    Not in our library10.1016/s0022-5193(03)00288-1

  131. 131.

    Ruiz-Palacios G. M. (2007 ). The health burden of Campylobacter infection and the impact of antimicrobial resistance: playing chicken. Clin. Infect. Dis. 44 701–703

    Not in our library10.1086/509936

  132. 132.

    Saier M. H. Jr. Paulsen I. T. (2001 ). Phylogeny of multidrug transporters. Semin. Cell Dev. Biol. 12 205–213

    Not in our library10.1006/scdb.2000.0246

  133. 133.

    Saier M. H. Jr. Paulsen I. T. Sliwinski M. K. Pao S. S. Skurray R. A. Nikaido H. (1998 ). Evolutionary origins of multidrug and drug-specific efflux pumps in bacteria. FASEB J. 12 265–274

    Not in our library10.1096/fasebj.12.3.265

  134. 134.

    Sanchez P. Alonso A. Martinez J. L. (2002a ). Cloning and characterization of SmeT, a repressor of the Stenotrophomonas maltophilia multidrug efflux pump SmeDEF. Antimicrob. Agents Chemother. 46 3386–3393

    Not in our library10.1128/aac.46.11.3386-3393.2002

  135. 135.

    Sanchez P. Linares J. F. Ruiz-Diez B. Campanario E. Navas A. Baquero F. (2002b ). Fitness of in vitro selected Pseudomonas aeruginosa nalB and nfxB multidrug resistant mutants. J. Antimicrob. Chemother. 50 657–664

    Not in our library10.1093/jac/dkf185

  136. 136.

    Sanchez P. Rojo F. Martinez J. L. (2002c ). Transcriptional regulation of mexR, the repressor of Pseudomonas aeruginosa mexAB-oprM multidrug efflux pump. FEMS Microbiol. Lett. 207 63–68

    Not in our library10.1111/j.1574-6968.2002.tb11029.x

  137. 137.

    Schuster M. Lostroh C. P. Ogi T. Greenberg E. P. (2003 ). Identification, timing, and signal specificity of Pseudomonas aeruginosa quorum-controlled genes: a transcriptome analysis. J. Bacteriol. 185 2066–2079

    Not in our library10.1128/jb.185.7.2066-2079.2003

  138. 138.

    Sekiya H. Mima T. Morita Y. Kuroda T. Mizushima T. Tsuchiya T. (2003 ). Functional cloning and characterization of a multidrug efflux pump, mexHI-opmD, from a Pseudomonas aeruginosa mutant. Antimicrob. Agents Chemother. 47 2990–2992

    Not in our library10.1128/aac.47.9.2990-2992.2003

  139. 139.

    Shafer W. M. Qu X. Waring A. J. Lehrer R. I. (1998 ). Modulation of Neisseria gonorrhoeae susceptibility to vertebrate antibacterial peptides due to a member of the resistance/nodulation/division efflux pump family. Proc. Natl. Acad. Sci. U.S.A. 95 1829–1833

    Not in our library10.1073/pnas.95.4.1829

  140. 140.

    Shao C. Zhang Q. Sun Y. Liu Z. Zeng J. Zhou Y. (2008 ). Helicobacter pylori protein response to human bile stress. J. Med. Microbiol. 57 151–158

    Not in our library10.1099/jmm.0.47616-0

  141. 141.

    Stahler F. N. Odenbreit S. Haas R. Wilrich J. Van Vliet A. H. Kusters J. G. (2006 ). The novel Helicobacter pylori CznABC metal efflux pump is required for cadmium, zinc, and nickel resistance, urease modulation, and gastric colonization. Infect. Immun. 74 3845–3852

    Not in our library10.1128/iai.02025-05

  142. 142.

    Stone T. W. Forrest C. M. Stoy N. Darlington L. G. (2012 ). Involvement of kynurenines in Huntington’s disease and stroke-induced brain damage. J. Neural. Transm. 119 261–274

    Not in our library10.1007/s00702-011-0676-8

  143. 143.

    Stoof J. Belzer C Van Vliet A. H. M. (2008 ). “Metal metabolism and transport in Helicobacter pylori,” in Helicobacter pylori: Molecular Genetics and Cellular Biology, ed Yamaoka Y. (Norfolk: Caister Academic Press) 165–177

    Not in our library

  144. 144.

    Tahlan K. Wilson R. Kastrinsky D. B. Arora K. Nair V. Fischer E. (2012 ). SQ109 targets MmpL3, a membrane transporter of trehalose monomycolate involved in mycolic acid donation to the cell wall core of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 56 1797–1809

    Not in our library10.1128/aac.05708-11

  145. 145.

    Taylor D. L. Bina X. R. Bina J. E. (2012 ). Vibrio cholerae VexH encodes a multiple drug efflux pump that contributes to the production of cholera toxin and the toxin co-regulated pilus. PLoS ONE 7:e38208

    Not in our library10.1371/journal.pone.0038208

  146. 146.

    Teran W. Felipe A. Segura A. Rojas A. Ramos J. L. Gallegos M. T. (2003 ). Antibiotic-dependent induction of Pseudomonas putida DOT-T1E TtgABC efflux pump is mediated by the drug binding repressor TtgR. Antimicrob. Agents Chemother. 47 3067–3072

    Not in our library10.1128/aac.47.10.3067-3072.2003

  147. 147.

    Tian Z. X. Fargier E. Mac Aogain M. Adams C. Wang Y. P O’Gara F. (2009a ). Transcriptome profiling defines a novel regulon modulated by the LysR-type transcriptional regulator MexT in Pseudomonas aeruginosa. Nucleic Acids Res. 37 7546–7559

    Not in our library10.1093/nar/gkp828

  148. 148.

    Tian Z. X. Mac Aogain M. O’Connor H. F. Fargier E. Mooij M. J. Adams C. (2009b ). MexT modulates virulence determinants in Pseudomonas aeruginosa independent of the MexEF-OprN efflux pump. Microb. Pathog. 47 237–241

    Not in our library10.1016/j.micpath.2009.08.003

  149. 149.

    Tomb J. F. White O. Kerlavage A. R. Clayton R. A. Sutton G. G. Fleischmann R. D. (1997 ). The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature 388 539–547

    Not in our library10.1038/41483

  150. 150.

    Trainor E. A. Horton K. E. Savage P. B. Testerman T. L. Mcgee D. J. (2011 ). Role of the HefC efflux pump in Helicobacter pylori cholesterol-dependent resistance to ceragenins and bile salts. Infect. Immun. 79 88–97

    Not in our library10.1128/iai.00974-09

  151. 151.

    Trotonda M. P. Tamber S. Memmi G. Cheung A. L. (2008 ). MgrA represses biofilm formation in Staphylococcus aureus. Infect. Immun. 76 5645–5654

    Not in our library10.1128/iai.00735-08

  152. 152.

    Truong-Bolduc Q. C. Dunman P. M. Strahilevitz J. Projan S. J. Hooper D. C. (2005 ). MgrA is a multiple regulator of two new efflux pumps in Staphylococcus aureus. J. Bacteriol. 187 2395–2405

    Not in our library10.1128/jb.187.7.2395-2405.2005

  153. 153.

    Truong-Bolduc Q. C. Zhang X. Hooper D. C. (2003 ). Characterization of NorR protein, a multifunctional regulator of norA expression in Staphylococcus aureus. J. Bacteriol. 185 3127–3138

    Not in our library10.1128/jb.185.10.3127-3138.2003

  154. 154.

    Tsugawa H. Suzuki H. Muraoka H. Ikeda F. Hirata K. Matsuzaki J. (2011 ). Enhanced bacterial efflux system is the first step to the development of metronidazole resistance in Helicobacter pylori. Biochem. Biophys. Res. Commun. 404 656–660

    Not in our library10.1016/j.bbrc.2010.12.034

  155. 155.

    Tullius M. V. Harmston C. A. Owens C. P. Chim N. Morse R. P. Mcmath L. M. (2011 ). Discovery and characterization of a unique mycobacterial heme acquisition system. Proc. Natl. Acad. Sci. U.S.A. 108 5051–5056

    Not in our library10.1073/pnas.1009516108

  156. 156.

    van Vliet A. H. Kuipers E. J. Waidner B. Davies B. J. De Vries N. Penn C. W. (2001 ). Nickel-responsive induction of urease expression in Helicobacter pylori is mediated at the transcriptional level. Infect. Immun. 69 4891–4897

    Not in our library10.1128/iai.69.8.4891-4897.2001

  157. 157.

    Veal W. L. Nicholas R. A. Shafer W. M. (2002 ). Overexpression of the MtrC-MtrD-MtrE efflux pump due to an mtrR mutation is required for chromosomally mediated penicillin resistance in Neisseria gonorrhoeae. J. Bacteriol. 184 5619–5624

    Not in our library10.1128/jb.184.20.5619-5624.2002

  158. 158.

    Vila J. Martinez J. L. (2008 ). Clinical impact of the over-expression of efflux pump in nonfermentative gram-negative bacilli, development of efflux pump inhibitors. Curr. Drug Targets 9 797–807

    Not in our library10.2174/138945008785747806

  159. 159.

    Waidner B. Melchers K. Ivanov I. Loferer H. Bensch K. W. Kist M. (2002 ). Identification by RNA profiling and mutational analysis of the novel copper resistance determinants CrdA (HP1326), CrdB (HP1327), and CzcB (HP1328) in Helicobacter pylori. J. Bacteriol. 184 6700–6708

    Not in our library10.1128/jb.184.23.6700-6708.2002

  160. 160.

    Waidner B. Melchers K. Stahler F. N. Kist M. Bereswill S. (2005 ). The Helicobacter pylori CrdRS two-component regulation system (HP1364/HP1365) is required for copper-mediated induction of the copper resistance determinant CrdA. J. Bacteriol. 187 4683–4688

    Not in our library10.1128/jb.187.13.4683-4688.2005

  161. 161.

    Warner D. M. Folster J. P. Shafer W. M. Jerse A. E. (2007 ). Regulation of the MtrC-MtrD-MtrE efflux-pump system modulates the in vivo fitness of Neisseria gonorrhoeae. J. Infect. Dis. 196 1804–1812

    Not in our library10.1086/522964

  162. 162.

    Webb V. Davies J. (1993 ). Antibiotic preparations contain DNA: a source of drug resistance genes? Antimicrob. Agents Chemother. 37 2379–2384

    Not in our library10.1128/aac.37.11.2379

  163. 163.

    Webber M. A. Piddock L. J. (2003 ). The importance of efflux pumps in bacterial antibiotic resistance. J. Antimicrob. Chemother. 51 9–11

    Not in our library10.1093/jac/dkg050

  164. 164.

    Worku M. L. Karim Q. N. Spencer J. Sidebotham R. L. (2004 ). Chemotactic response of Helicobacter pylori to human plasma and bile. J. Med. Microbiol. 53 807–811

    Not in our library10.1099/jmm.0.45636-0

  165. 165.

    Wu C. P. Hsieh C. H. Wu Y. S. (2011 ). The emergence of drug transporter-mediated multidrug resistance to cancer chemotherapy. Mol. Pharm. 8 1996–2011

    Not in our library10.1021/mp200261n

  166. 166.

    Yamamoto K. Ishihama A. (2005 ). Transcriptional response of Escherichia coli to external copper. Mol. Microbiol. 56 215–227

    Not in our library10.1111/j.1365-2958.2005.04532.x

  167. 167.

    Zhang A. Rosner J. L. Martin R. G. (2008 ). Transcriptional activation by MarA, SoxS and Rob of two tolC promoters using one binding site: a complex promoter configuration for tolC in Escherichia coli. Mol. Microbiol. 69 1450–1455

    Not in our library10.1111/j.1365-2958.2008.06371.x

Cited by papers we hold 10

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.